BN Business News
Aggiungi la tua azienda →
Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.

Energia e ambiente · 26/04/19941 min di lettura

Rulemaking for the Pharmaceuticals Manufacturing Industry Notice of Public Meeting

Traduzione automatica locale · Lingua originale della fonte

Riepilogo

The U.S. Environmental Protection Agency (EPA) is developing regulations that will apply to the pharmaceuticals manufacturing industry. The regulations are scheduled to be proposed in August 1994, and EPA is sponsoring a public meeting prior to proposal. EPA is developing effluent limitations guidelines and standards under authority of the clean Water Act. The Agency plans to proceed with this rulemaking and coordinate this effort with the development of maximum achievable control technology standards under authority of the Clean Water Act. These standards are due to be developed on a separate schedule. The public meeting is intended to be a forum in which EPA can report on the status of regulatory development and in which interested parties can provide information and ideas on key technical, scientific, and other issues. Other agenda topics for this public meeting include a summary of data collection activities, options development and preliminary technology-based options selection. A document relating to the above topics and a more detailed agenda will be available at the meeting.

Lingua originale della fonte: Federal Register — Environmental Protection AgencyApri il comunicato originale →

Esplora gli approfondimenti

Analisi aziendali →